Vertex Pharmaceuticals Incorporated (FRA:VX1)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	102,831	97,968	100,171	94,857	69,361	49,095
Market Cap Growth	-14.84%	-2.20%	5.60%	36.76%	41.28%	-2.28%
Enterprise Value	94,102	89,302	91,039	83,201	60,990	43,745
Last Close Price	404.85	389.10	389.95	369.65	269.95	198.02
PE Ratio	30.54	29.10	-	28.97	22.31	23.84
PS Ratio	10.06	9.58	9.41	10.62	8.30	7.37
PB Ratio	6.47	6.16	6.32	5.96	5.33	5.53
P/TBV Ratio	7.04	6.71	7.15	6.70	6.07	6.42
P/FCF Ratio	37.80	36.02	-	31.42	18.89	23.18
P/OCF Ratio	33.25	31.68	-	29.64	17.95	21.12
EV/Sales Ratio	9.24	8.74	8.55	9.32	7.30	6.57
EV/EBITDA Ratio	21.69	21.55	20.59	20.54	14.40	12.38
EV/EBIT Ratio	23.65	22.37	21.45	21.35	14.89	12.78
EV/FCF Ratio	34.59	32.83	-	27.56	16.61	20.66
Debt / Equity Ratio	0.11	0.11	0.11	0.05	0.07	0.10
Debt / EBITDA Ratio	0.40	0.40	0.37	0.18	0.20	0.24
Debt / FCF Ratio	0.64	0.64	-	0.24	0.23	0.40
Net Debt / Equity Ratio	-0.55	-0.55	-0.58	-0.73	-0.72	-0.65
Net Debt / EBITDA Ratio	-2.11	-2.11	-2.07	-2.88	-2.21	-1.63
Net Debt / FCF Ratio	-3.22	-3.22	11.99	-3.87	-2.54	-2.72
Asset Turnover	0.50	0.50	0.49	0.48	0.57	0.60
Inventory Turnover	3.85	3.85	5.31	7.38	8.87	8.97
Quick Ratio	2.24	2.24	2.17	3.60	4.46	4.04
Current Ratio	2.90	2.90	2.69	3.99	4.83	4.46
Return on Equity (ROE)	22.54%	22.54%	-3.15%	22.99%	27.67%	24.93%
Return on Assets (ROA)	12.16%	12.16%	12.14%	13.17%	17.33%	19.32%
Return on Invested Capital (ROIC)	29.60%	30.54%	-98.60%	63.54%	90.72%	102.53%
Return on Capital Employed (ROCE)	21.50%	21.50%	23.20%	22.50%	28.40%	34.50%
Earnings Yield	3.27%	3.44%	-0.52%	3.45%	4.48%	4.20%
FCF Yield	2.65%	2.78%	-0.76%	3.18%	5.29%	4.31%
Buyback Yield / Dilution	-0.04%	-0.04%	1.00%	-0.54%	0.31%	1.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.